Monitoring

Monitoring should be tailored to CKD severity and individual risk. The table below shows the minimum frequency of monitoring suggested by NICE for each CKD category (G#A#). The frequency of eGFR and uACR testing should be agreed with the person and adjusted according to CKD cause, progression, risk factors, treatment changes, intercurrent illness, and management approach.